Skip to main content
SpringerLink
Log in

Rheumatoid Arthritis-Associated Interstitial Lung Disease

  • Chapter
  • First Online:
Lung Disease in Rheumatoid Arthritis

Part of the book series: Respiratory Medicine ((RM))

Abstract

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a frequent and clinically important extra-articular manifestation of RA. Although most patients with RA-ILD will experience disease progression over time, RA-ILD encompasses a wide range of disease severity. Early recognition of RA-ILD is essential to ensure adequate patient care. This chapter will review the epidemiology, clinical presentation, evaluation, diagnosis, and natural history of RA-ILD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010;62(6):1583–91.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Olson AL, Swigris JJ, Sprunger DB, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372–8.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kim EJ, Elicker BM, Maldonado F, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010;35(6):1322–8.

    Article  CAS  PubMed  Google Scholar 

  5. Ellman P, Ball RE. Rheumatoid disease with joint and pulmonary manifestations. Br Med J. 1948;2(4583):816–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax. 2001;56(8):622–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gochuico BR, Avila NA, Chow CK, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008;168(2):159–66.

    Article  CAS  PubMed  Google Scholar 

  8. Richman NC, Yazdany J, Graf J, Chernitskiy V, Imboden JB. Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Medicine. 2013;92(2):92–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zrour SH, Touzi M, Bejia I, et al. Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients. Joint Bone Spine. 2005;72(1):41–7.

    Article  PubMed  Google Scholar 

  10. Norton S, Koduri G, Nikiphorou E, Dixey J, Williams P, Young A. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology (Oxford). 2013;52(1):99–110.

    Article  Google Scholar 

  11. Zou YQ, Li YS, Ding XN, Ying ZH. The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China. Rheumatol Int. 2012;32(3):669–73.

    Article  PubMed  Google Scholar 

  12. Carmona L, Gonzalez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmarti R. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003;62(9):897–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Mori S, Cho I, Koga Y, Sugimoto M. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol. 2008;35(8):1513–21.

    PubMed  Google Scholar 

  14. Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med. 1997;156(2 Pt 1):528–35.

    Article  CAS  PubMed  Google Scholar 

  15. Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med. 1973;54(4):445–52.

    Article  CAS  PubMed  Google Scholar 

  16. Stack BH, Grant IW. Rheumatoid interstitial lung disease. Br J Dis Chest. 1965;59(4):202–11.

    Article  CAS  PubMed  Google Scholar 

  17. Padley SP, Hansell DM, Flower CD, Jennings P. Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease. Clin Radiol. 1991;44(4):222–6.

    Article  CAS  PubMed  Google Scholar 

  18. Chen J, Shi Y, Wang X, Huang H, Ascherman D. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin Dev Immunol. 2013;2013:406927.

    PubMed  PubMed Central  Google Scholar 

  19. Carotti M, Salaffi F, Manganelli P, Salvolini L, Bichi Secchi E, De Berardinis S. The subclinical involvement of the lung in rheumatoid arthritis: evaluation by high-resolution computed tomography. Reumatismo. 2001;53(4):280–8.

    PubMed  Google Scholar 

  20. Turesson C, Eberhardt K, Jacobsson LT, Lindqvist E. Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort. Ann Rheum Dis. 2007;66(11):1543–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Doyle TJ, Patel AS, Hatabu H, et al. Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers. Am J Respir Crit Care Med. 2015;191(12):1403–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Mori S, Koga Y, Sugimoto M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med. 2012;106(11):1591–9.

    Article  PubMed  Google Scholar 

  23. Kelly CA, Saravanan V, Nisar M, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics—a large multicentre UK study. Rheumatology (Oxford). 2014;53(9):1676–82.

    Article  CAS  Google Scholar 

  24. Weyand CM, Schmidt D, Wagner U, Goronzy JJ. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum. 1998;41(5):817–22.

    Article  CAS  PubMed  Google Scholar 

  25. Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol. 2006;35(3):169–74.

    Article  CAS  PubMed  Google Scholar 

  26. Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis. 1997;56(8):463–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Giles JT, Danoff SK, Sokolove J, et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis. 2014;73(8):1487–94.

    Article  CAS  PubMed  Google Scholar 

  28. Mori S, Cho I, Koga Y, Sugimoto M. A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol. 2008;18(1):60–6.

    Article  PubMed  Google Scholar 

  29. Fischer A, Solomon JJ, du Bois RM, et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med. 2012;106(7):1040–7.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Brannan HM, Good CA, Divertie MB, Baggenstoss AH. Pulmonary disease associated with rheumatoid arthritis. JAMA. 1964;189:914–8.

    Article  CAS  PubMed  Google Scholar 

  31. Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr. 1999;23(6):941–8.

    Article  CAS  PubMed  Google Scholar 

  32. Nurmi HM, Purokivi MK, Karkkainen MS, Kettunen HP, Selander TA, Kaarteenaho RL. Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes. BMC Pulm Med. 2016;16(1):107.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Gizinski AM, Mascolo M, Loucks JL, et al. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clin Rheumatol. 2009;28(5):611–3.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Zayeni H, Haji-Abbasi A, Foumani SA, et al. Pulmonary involvement in rheumatoid arthritis: a cross-sectional study in Iran. Lung India. 2016;33(1):49–52.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Wang JX, Du CG. A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients. Med Sci Monit. 2015;21:708–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Mohd Noor N, Mohd Shahrir MS, Shahid MS, Abdul Manap R, Shahizon Azura AM, Azhar Shah S. Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease. Int J Rheum Dis. 2009;12(2):136–44.

    Article  PubMed  Google Scholar 

  37. Saag KG, Kolluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum. 1996;39(10):1711–9.

    Article  CAS  PubMed  Google Scholar 

  38. Hamblin MJ, Horton MR. Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulm Med. 2011;2011:872120.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Skare TL, Nakano I, Escuissiato DL, Batistetti R, Rodrigues Tde O, Silva MB. Pulmonary changes on high-resolution computed tomography of patients with rheumatoid arthritis and their association with clinical, demographic, serological and therapeutic variables. Rev Bras Reumatol. 2011;51(4):325–30. 336–327.

    Article  PubMed  Google Scholar 

  40. Pappas DA, Giles JT, Connors G, Lechtzin N, Bathon JM, Danoff SK. Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study. Arthritis Res Ther. 2010;12(3):R104.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Doyle TJ, Dellaripa PF, Batra K, et al. Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis. Chest. 2014;146(1):41–50.

    Article  PubMed  Google Scholar 

  42. Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis. 2002;61(6):517–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67(10):1488–92.

    Article  CAS  PubMed  Google Scholar 

  45. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38–46.

    Article  CAS  PubMed  Google Scholar 

  46. Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976–87.

    Article  CAS  PubMed  Google Scholar 

  47. Chansakul T, Dellaripa PF, Doyle TJ, Madan R. Intra-thoracic rheumatoid arthritis: imaging spectrum of typical findings and treatment related complications. Eur J Radiol. 2015;84(10):1981–91.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Curtis JR, Sarsour K, Napalkov P, Costa LA, Schulman KL. Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor alpha agents, a retrospective cohort study. Arthritis Res Ther. 2015;17:319.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Roubille C, Haraoui B. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum. 2014;43(5):613–26.

    Article  CAS  PubMed  Google Scholar 

  50. Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum. 2006;54(5):1435–9.

    Article  CAS  PubMed  Google Scholar 

  51. Camus P, Kudoh S, Ebina M. Interstitial lung disease associated with drug therapy. Br J Cancer. 2004;91(Suppl 2):S18–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004;71(4):301–26.

    Article  PubMed  Google Scholar 

  53. Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL. Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol. 2016;35(10):2585–9.

    Article  PubMed  Google Scholar 

  54. Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004;232(1):81–91.

    Article  PubMed  Google Scholar 

  55. Assayag D, Elicker BM, Urbania TH, et al. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology. 2014;270(2):583–8.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Biederer J, Schnabel A, Muhle C, Gross WL, Heller M, Reuter M. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol. 2004;14(2):272–80.

    Article  CAS  PubMed  Google Scholar 

  57. Perez T, Farre JM, Gosset P, et al. Subclinical alveolar inflammation in rheumatoid arthritis: superoxide anion, neutrophil chemotactic activity and fibronectin generation by alveolar macrophages. Eur Respir J. 1989;2(1):7–13.

    CAS  PubMed  Google Scholar 

  58. Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127(6):2019–27.

    Article  PubMed  Google Scholar 

  59. Solomon JJ, Ryu JH, Tazelaar HD, et al. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med. 2013;107(8):1247–52.

    Article  PubMed  Google Scholar 

  60. Assayag D, Lee JS, King TE Jr. Rheumatoid arthritis associated interstitial lung disease: a review. Medicina. 2014;74(2):158–65.

    PubMed  Google Scholar 

  61. Tsuchiya Y, Takayanagi N, Sugiura H, et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J. 2011;37(6):1411–7.

    Article  CAS  PubMed  Google Scholar 

  62. Song JW, Lee HK, Lee CK, et al. Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(2):103–12.

    CAS  PubMed  Google Scholar 

  63. Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2007;46(2):350–7.

    Article  CAS  Google Scholar 

  64. Suzuki A, Ohosone Y, Obana M, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 1994;21(1):33–6.

    CAS  PubMed  Google Scholar 

  65. Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48(6):1530–42.

    Article  PubMed  Google Scholar 

  66. Dixon WG, Hyrich KL, Watson KD, Lunt M, Symmons DP. Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2010;69(6):1086–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford). 2010;49(8):1483–9.

    Article  Google Scholar 

  68. Solomon JJ, Chung JH, Cosgrove GP, et al. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2016;47(2):588–96.

    Article  PubMed  Google Scholar 

  69. Assayag D, Lubin M, Lee JS, King TE, Collard HR, Ryerson CJ. Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology. 2014;19(4):493–500.

    Article  PubMed  Google Scholar 

  70. Hozumi H, Nakamura Y, Johkoh T, et al. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open. 2013;3(9):e003132.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de Médecine, Centre Hospitalier de l’Université de Montréal, Montréal, QC, Canada

    Julie Morisset MD

  2. Department of Medicine, University of Colorado Denver, Aurora, CO, USA

    Joyce S. Lee MD, MAS

Authors
  1. Julie Morisset MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joyce S. Lee MD, MAS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joyce S. Lee MD, MAS .

Editor information

Editors and Affiliations

  1. Division of Rheumatology, Division of Pulmonary Sciences and Critical Care, Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA

    Aryeh Fischer

  2. Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA

    Joyce S. Lee

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Morisset, J., Lee, J.S. (2018). Rheumatoid Arthritis-Associated Interstitial Lung Disease. In: Fischer, A., Lee, J. (eds) Lung Disease in Rheumatoid Arthritis. Respiratory Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-68888-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-68888-6_8

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-68887-9

  • Online ISBN: 978-3-319-68888-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation